FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver CancerBusiness Wire • 09/09/21
Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare ConferenceBusiness Wire • 09/02/21
NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/29/21
Novocure Reports Second Quarter 2021 Financial Results and Provides Company UpdateBusiness Wire • 07/29/21
Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research ProgramBusiness Wire • 07/15/21
Novocure Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver CancerBusiness Wire • 07/01/21